Olema Pharmaceuticals, Inc. (OLMA)
NASDAQ: OLMA · IEX Real-Time Price · USD
15.19
+0.04 (0.26%)
At close: Jul 23, 2024, 4:00 PM
15.31
+0.12 (0.79%)
After-hours: Jul 23, 2024, 4:08 PM EDT

Olema Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year Ending
TTM Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019 2018
Selling, General & Admin
16.518.8224.7120.397.820.4
Upgrade
Research & Development
93.286.1482.2751.113.73.92
Upgrade
Operating Expenses
109.7104.96106.9971.4921.534.32
Upgrade
Operating Income
-109.7-104.96-106.99-71.49-21.53-4.32
Upgrade
Interest Expense / Income
00000.650
Upgrade
Other Expense / Income
-10.36-8.31-2.2-0.4-0.06-0.01
Upgrade
Pretax Income
-99.34-96.66-104.79-71.1-22.12-4.32
Upgrade
Net Income
-99.34-96.66-104.79-71.1-22.12-4.32
Upgrade
Preferred Dividends
00001.870
Upgrade
Net Income Common
-99.34-96.66-104.79-71.1-23.99-4.32
Upgrade
Shares Outstanding (Basic)
5645404073
Upgrade
Shares Outstanding (Diluted)
5645404073
Upgrade
Shares Change
37.72%13.13%1.19%462.91%170.75%2.80%
Upgrade
EPS (Basic)
-2.01-2.14-2.62-1.80-3.42-1.66
Upgrade
EPS (Diluted)
-2.01-2.14-2.62-1.80-3.42-1.66
Upgrade
Free Cash Flow
-86.97-83.71-82.43-52.27-19.92-3.08
Upgrade
Free Cash Flow Per Share
-1.56-1.85-2.06-1.32-2.84-1.19
Upgrade
EBITDA
-97.72-94.98-103.13-69.71-21.46-4.31
Upgrade
Depreciation & Amortization
1.621.671.661.390.010.01
Upgrade
EBIT
-99.34-96.66-104.79-71.1-21.47-4.32
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).